Italfarmaco S.p.A. and JCR Pharmaceuticals Co., Ltd. (TSE 4552; "JCR"), today announced an exclusive licensing agreement for the development and commercialisation of givinostat in Japan. Under the ...
Discover why Edgewise Therapeutics, Inc. is rated Buy amid strong trial data, unique HCM treatment, and major 2026 catalysts. Click for this EWTX update.
As of Wednesday, December 24, Edgewise Therapeutics, Inc.’s EWTX share price has surged by 20.17%, which has investors questioning if this is right time to sell.
California-based Foresite Capital Management VI fully exited Edgewise Therapeutics (NASDAQ:EWTX) in the quarter ended ...
Precision BioSciences offers high-risk, high-reward potential, trading below cash with key HBV and DMD data catalysts ...
Becker’s has compiled a list of the hospitals patients are most likely to recommend in every state using Hospital Consumer Assessment of Healthcare Providers and Systems data from CMS. CMS shares 10 ...
Maki Becker is a senior reporter at WKBW 7 News. She joined 7 News in January as part of the E.W. Scripps Journalism Journey Initiative through which veteran print journalists learn how to become ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback